CRED NPM

Speaker Biographies

Christelle Anquez-Traxler Christelle Anquez-Traxler is Senior Regulatory Science and Strategy Lead at AESGP which is the European Association representing the selfcare industry. Her focus has always been on regulatory and science of non-prescription medicinal products with a particular passion for switch. She has been with AESGP 20 years and previously had been working in international affairs for the US FDA. She is a pharmacist by training with specialisation in regulatory affairs and health economics Klavdija Kmetic Klavdija Kmetic is the Regulatory Affairs and Policy Manager at the Association of the European Self-Care Industry (AESGP) in Brussels. In this role, she monitors regulatory, policy, and legislative developments affecting the self-care sector, with a particular focus on non prescription medicines and food supplements. Klavdija actively supports and contributes to the work of the AESGP Regulatory Affairs Committee and the work of dedicated expert groups. Additionally, she leads the AESGP expert group on switch and is passionate about improving the switch process and promoting switch to better support the self-care agenda in Europe. Michelle Riddalls Michelle Riddalls is Chief Executive of PAGB, the consumer healthcare association, which represents the manufacturers of branded over-the-counter (OTC) medicines, self-care medical devices and food supplements in the UK. Michelle is the leading spokesperson for the OTC sector on issues such as Brexit, self-care, reclassification and regulatory challenges. As part of this, Michelle has provided evidence to the House of Lords, and works closely with the Medicines and Healthcare products Regulatory Agency, Department of Health and Social Care, Office of Life Sciences and Number 10. Michelle is an expert in consumer healthcare regulation having worked in the sector for over two decades and has driven a number of successful product switches. She has received awards from TOPRA for her work in POM to OTC reclassifications and she was recognised by the Women in Trade Associations Power list in 2023 and 2024. Prior to joining PAGB, Michelle was Director of Regulatory Affairs for the Northern European Cluster at Pfizer Consumer Healthcare, where she was integral in the highly successful POM to GSL reclassification of Nexium Control and the Viagra Connect POM to P switch.